Islamic-Oriented vs. Standard Ericksonian Hypnotherapy for Anxiety and Depression
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorIstanbul Nisantasi University
About this trial
This randomized controlled trial (RCT) aims to compare the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in reducing symptoms of anxiety and depression. The study will enroll 90 participants with mild to moderate anxiety and depression, who will be randomly assigned to one of three groups: (1) IEH intervention, (2) SEH intervention, or (3) control group (no intervention). Participants in the intervention groups will receive 12 weekly hypnotherapy sessions, each lasting 60 minutes. The primary outcomes include changes in Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores from baseline to post-intervention and at a 4-week follow-up.
The study will also assess whether religious belief levels moderate the effects of the intervention using the OK-Religious Attitude Scale. Data collection will be performed at Istanbul Nişantaşı University, and ethical approval has been obtained.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Muslim individuals aged 18-65 years.
Mild to moderate anxiety and/or depression symptoms (assessed via Beck
Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI)).
No formal psychiatric diagnosis but experiencing psychological distress.
Disqualifiers
Severe psychiatric disorders (schizophrenia, bipolar disorder, severe MDD).
Current use of psychotropic medication or undergoing psychotherapy.
History of substance abuse or dependence.
Diagnosed dissociative disorders (contraindications for hypnosis).
Trial design
Design model
Parallel
Treatments tested in this trial
Islamic-Oriented Ericksonian Hypnotherapy (IEH)
BehavioralThis intervention involves 12 weekly sessions (60 minutes each) of Ericksonian hypnotherapy integrated with Islamic religious elements. Sessions incorporate: Quranic metaphors and Islamic imagery Spiritual affirmations to enhance relaxation and emotional regulation Faith-based guided hypnosis adapted to cultural and religious beliefs Techniques such as indirect suggestions, therapeutic storytelling, and guided imagery The intervention is designed for Muslim participants with mild to moderate anxiety and depression.
Standard Ericksonian Hypnotherapy (SEH)
BehavioralParticipants receive 12 weekly sessions (60 minutes each) of standard Ericksonian hypnotherapy, which includes: Metaphorical storytelling and guided imagery Indirect hypnotic suggestions to promote psychological flexibility Relaxation techniques to reduce anxiety and depressive symptoms Unlike the Islamic-Oriented Hypnotherapy (IEH), this intervention does not integrate religious or faith-based elements.
Treatment groups
90 Participants
are divided into 3 treatment groupsGroup A: Islamic-Oriented Ericksonian Hypnotherapy (IEH) GroupExperimental treatment 1 intervention
Group B: Standard Ericksonian Hypnotherapy (SEH) GroupActive comparator 1 intervention
Group C: Control Group (No Intervention)No intervention 0 interventions
Trial outcomes
Primary outcomes
1
Beck Depression Inventory-II (BDI-II)
The study evaluates the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) vs. Standard Ericksonian Hypnotherapy (SEH) vs. No Intervention in reducing depressive symptoms. Depression severity will be assessed using the Beck Depression Inventory-II (BDI-II), comparing baseline, post-intervention (Week 12), and follow-up (Week 16) scores.
Time frame
Baseline, Week 12 (post-intervention), Week 16 (follow-up)2
Beck Anxiety Inventory (BAI)
The study measures reductions in anxiety symptoms among participants receiving IEH, SEH, or no intervention. Anxiety severity will be assessed using the Beck Anxiety Inventory (BAI), comparing scores from baseline to post-intervention and follow-up.
Time frame
Baseline, Week 12, Week 16Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov